sofwave treatment loose skin thighs glp-1 Ozempic Legs: Why Weight Loss Changes & Cellulite Combat GLP 1 Skin Laxity

On average, volunteers in the retatrutide clinical trial who received the study drug rather than a placebo lost an average of 70.3 pounds over about a year-and-a-half, with more than 45% of participants losing more than 30% of their body weight

Mounjaro is a newer medication that acts on both GLP-1 and GIP receptors, making it more effective than Ozempic for weight loss and blood sugar control in some patients

After reconstitution, store the vial upright in a refrigerator at 2 to 8 degrees Celsius

Despite this, 76% of former users say they are now eating the same amount or less than when on the medication

The trial was overseen and sponsored by Novo Nordisk